Recent years have witnessed remarkable developments in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://roxannmqcu862340.tribunablog.com/glp-1-receptor-agonists-retatrutide-and-trizepatide-advancements-53323714